These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29018343)

  • 41. Specific labelling of gastric H+,K+-ATPase by omeprazole.
    Fryklund J; Gedda K; Wallmark B
    Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibility.
    Lee RD; Vakily M; Mulford D; Wu J; Atkinson SN
    Aliment Pharmacol Ther; 2009 Apr; 29(8):824-33. PubMed ID: 19243357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. E3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretion.
    Kodama K; Fujisaki H; Kubota A; Kato H; Hirota K; Kuramochi H; Murota M; Tabata Y; Ueda M; Harada H; Kawahara T; Shinoda M; Watanabe N; Iida D; Terauchi H; Yasui S; Miyazawa S; Nagakawa J
    J Pharmacol Exp Ther; 2010 Aug; 334(2):395-401. PubMed ID: 20484556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Negative regulation of gastric proton pump by desialylation suggested by fluorescent imaging with the sialic acid-specific nanoprobe].
    Fujii T; Shimizu T; Kushiro K; Takeshima H; Takai M; Sakai H
    Nihon Yakurigaku Zasshi; 2019; 153(6):261-266. PubMed ID: 31178530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
    Ram M R; Teh X; Rajakumar T; Goh KL; Leow AHR; Poh BH; Mariappan V; Shankar EM; Loke MF; Vadivelu J
    J Antimicrob Chemother; 2019 Jan; 74(1):11-16. PubMed ID: 30403784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Designed inhibitors with hetero linkers for gastric proton pump H
    Jana K; Bandyopadhyay T; Ganguly B
    J Mol Graph Model; 2017 Nov; 78():129-138. PubMed ID: 29055186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule.
    Kukulka M; Nudurupati S; Perez MC
    Therap Adv Gastroenterol; 2016 Nov; 9(6):770-780. PubMed ID: 27803732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
    Koop H; Kuly S; Flüg M; Eissele R; Mönnikes H; Rose K; Lühmann R; Schneider A; Fischer R; Arnold R
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):915-8. PubMed ID: 8889461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients.
    Oh JH; Choi MG; Dong MS; Park JM; Paik CN; Cho YK; Jeong JJ; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1429-34. PubMed ID: 17645482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastric Juice-Based Real-Time PCR for Tailored
    Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
    Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem.
    Byeon JY; Kim YH; Kim SH; Lee CM; Jung EH; Chae WK; Jang CG; Lee SY; Lee YJ
    Arch Pharm Res; 2018 Aug; 41(8):861-866. PubMed ID: 30117082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Nagai H
    Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulations in extracellular calcium lead to H
    Kitay AM; Schneebacher MT; Schmitt A; Heschl K; Kopic S; Alfadda T; Alsaihati A; Link A; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G36-G42. PubMed ID: 29517927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.
    Scott DR; Munson KB; Marcus EA; Lambrecht NW; Sachs G
    Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1315-26. PubMed ID: 26423447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring].
    Kihira K; Yoshida Y; Kasano T; Taniguchi Y; Sato K; Kimura K; Hirose M; Koyama H
    Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):672-80. PubMed ID: 1646341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.